AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

8.310

+0.2703.36%

Volume:120.51K

Turnover:987.30K

Market Cap:417.17M

PE:12.44

High:8.330

Open:8.100

Low:8.030

Close:8.040

52wk High:13.399

52wk Low:7.930

Shares:50.20M

Float Shares:41.32M

Volume Ratio:0.97

T/O Rate:0.29%

Dividend:0.05

Dividend Rate:0.60%

EPS(TTM):0.668

EPS(LYR):0.668

ROE:13.21%

ROA:8.94%

PB:1.53

PE(LYR):12.44

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CLINUVEL PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

1999

Employees:

16

Office Location:

535 Bourke Street,Level 22,Melbourne,Victoria,Australia

Website:

http://www.clinuvel.com

Zip Code:

3000

Phone:

Fax:

61 3 9660 4999

Introduction:

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/CUV.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":8.31,"timestamp":1789366320000,"preClose":8.04,"halted":0,"volume":120511,"delay":0,"changeRate":0.03358208955223898,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41318955,"shares":50200740,"eps":0.667999,"marketStatus":"Not Yet Opened","change":0.27,"latestTime":"09-14 16:12:00 AEST","open":8.1,"high":8.33,"low":8.03,"amount":987300,"amplitude":0.037313,"askPrice":8.4,"askSize":950,"bidPrice":8.28,"bidSize":120,"shortable":3,"etf":0,"ttmEps":0.667999,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":8.04,"dividendRate":0.006017,"openAndCloseTimeList":[[1789344000000,1789365600000]],"volumeRatio":0.9719710745137672,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CUV.AU","preClose":8.04,"auctionPrice":8.31,"auctionVolume":8338,"auction":3,"marketStatus":"盘后竞价","timestamp":1789366211153}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41318955,"roa":"8.94%","roe":"13.21%","lyrEps":0.667999,"volumeRatio":0.9719710745137672,"shares":50200740,"dividePrice":0.05,"high":8.33,"amplitude":0.037313,"preClose":8.04,"low":8.03,"week52Low":7.93,"pbRate":"1.53","psRate":"4.44","week52High":13.399,"institutionHeld":0,"latestPrice":8.31,"committee":-0.775701,"eps":0.667999,"divideRate":0.006017,"volume":120511,"delay":0,"ttmEps":0.667999,"open":8.1,"prevYearClose":12.385,"prevWeekClose":8.04,"prevMonthClose":7.972,"prevQuarterClose":10.219,"fiveDayClose":8.16,"twentyDayClose":9.731,"sixtyDayClose":10.109,"dividendPayoutRate":0.07372445631899688,"dividendFrequency":"A","dividendGrowthYears":6,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.0033959070154716284},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-03","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-04","defaultRemindTime":1788393600000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-04","currency":"AUD","dateTimestamp":1788357600000,"payDate":"2026-09-18"},{"date":"2026-08-27","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-09-04","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-19"},{"date":"2025-08-28","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4999","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":0.0184},{"period":"1month","weight":-0.1246},{"period":"3month","weight":-0.1059},{"period":"6month","weight":-0.1346},{"period":"1year","weight":-0.2114},{"period":"ytd","weight":-0.329}],"compareEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.0273},{"period":"6month","weight":0.0518},{"period":"1year","weight":0.0951},{"period":"ytd","weight":0.0343}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.36,"avgChangeRate":-0.039741},{"month":2,"riseRate":0.538462,"avgChangeRate":0.007472},{"month":3,"riseRate":0.5,"avgChangeRate":0.009409},{"month":4,"riseRate":0.538462,"avgChangeRate":0.047643},{"month":5,"riseRate":0.269231,"avgChangeRate":-0.045322},{"month":6,"riseRate":0.576923,"avgChangeRate":0.060972},{"month":7,"riseRate":0.576923,"avgChangeRate":0.051771},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002789},{"month":9,"riseRate":0.52,"avgChangeRate":0.020681},{"month":10,"riseRate":0.44,"avgChangeRate":0.03675},{"month":11,"riseRate":0.52,"avgChangeRate":0.025645},{"month":12,"riseRate":0.56,"avgChangeRate":0.06332}],"exchange":"ASX","name":"CLINUVEL PHARMACEUTICALS LTD","nameEN":"CLINUVEL PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":null}}